Do you want to read an article? Please log in or register.
Impact of benralizumab on airway structure/function in severe eosinophilic asthma
Asthma
RECOMMENDED
Related content
Asthma
Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study
Lancet Respir Med
Logan J, Martin K, Gillespie L, McConnachie A, Lee WN, Burhan H, Brown T, Faruqi S, Jackson DJ, Kurukulaaratchy R, Mansur AH, Saralaya D, Fowler SJ, Patel P, Brown J, Lordan J, Siddiqui S, Smith SJ, Shah PA, Haldar K, Megremis S, Harrison SA, Brown R, Nelson C, Mistry V, Brown V, Chalmers JD, Djukanovic R, Pavord ID, Heaney LG, Brightling CE, Chaudhuri R
doi: 10.1016/S2213-2600(26)00096-2
Asthma
Impact of Health Insurance Type on Access to Biologics and Systemic Corticosteroid Exposure in Patients With Severe Asthma: A Real-World Study From the Korean Severe Asthma Registry (KoSAR)
Allergy Asthma Immunol Res
Sohn KH, Lee SK, Lee HY, Kim SR, Lee SE, Kim JH, Song WJ, Kim SH, Korean Severe Asthma Registry (KoSAR) Investigators
doi: 10.4168/aair.2026.18.2.192
Asthma
Benralizumab In Severe Eosinophilic Asthma: A Real-Life Data From Türkiye
Respir Med
Çelebi Sözener Z, Özdel Öztürk B, Şahinoğlu E, Köylüce S, Türk M, Aydın Ö, Sin BA, Mungan D, Yılmaz İ, Bavbek S
doi: 10.1016/j.rmed.2025.108332
Asthma
Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain
J Clin Med
García-Moguel I, Agüero Calvo J, Betancor Pérez D, Carretero Gracia JÁ, Díaz-Campos RM, Fernández Martínez de Septien C, Gómez-Bastero Fernández A, Hernández Galván Y, Lloret-Queraltó JA, Lluch Tortajada I, Malanda NM, Martín-García C, Martínez Mesa Á, Martínez-Moragon E, Medina Gallardo JF, Padilla-Galo A, Pérez Chica G, Plasencia García I, Prieto Montaño P, Puchaes Manchón C, Romero Ribate D, Valverde-Monge M, Zamarro Parra MS, Sanchez-Trincado JL, Nuevo J, Luzon E, Velasco-Garrido JL
doi: 10.3390/jcm15124564
Asthma
Real-World Effectiveness Following Benralizumab Use in Patients with Severe Eosinophilic Asthma in Romania: A Retrospective Cohort Study (BREEZE)
J Clin Med
Toma CL, Teodorescu G, Mihălţan FD, Frent S, Ali S, Trenchea M, Constantin AA
doi: 10.3390/jcm15020425
Asthma
Benralizumab Reduces Asthma Exacerbations and Costs Among Medicare Beneficiaries with Severe Asthma: The ZEPHYR-5 Study
J Asthma Allergy
Adrish M, DeMartino JK, Carstens D, Jackson M, Schinkel J, Wilson K, Tkacz J
doi: 10.2147/JAA.S568990
COMMENTED
Asthma
Clinical Remission in Severe Asthma: A Comparative Analysis of Patients with and Without Biologics from the Swiss Severe Asthma Registry
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Biomedicines
Jaun F, Boesing M, Lüthi-Corridori G, Bridevaux PO, Charbonnier F, Clarenbach CF, Fellrath JM, Gianella P, Jochmann A, Kern L, Pavlov N, Latshang TD, Von Garnier C, Leuppi JD
doi: 10.3390/biomedicines13123074
RECOMMENDED
Asthma
Real-World Effectiveness and Safety of Mepolizumab in Pediatric Severe Eosinophilic Asthma: A Multicenter Study
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Pediatr Pulmonol
Çevik NN, Ocak M, Kocatepe G, Teker NB, Kocacik Uygun DF, Serbes M, Ozcan D, Bingol A, Sekerel BE
doi: 10.1002/ppul.71466
COMMENTED
Asthma
Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: A multicenter, randomized, double-blind, Phase 3A Clinical Trial (NIMBLE)
★ 3
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Am J Respir Crit Care Med
Chupp G, Nagase H, Skowasch D, Devouassoux G, Côté A, Jackson DJ, Jackson DJ, Wechsler ME, Imber V, McGinniss JE, K SO, Howarth P, Pavord ID, NIMBLE Study Investigators
doi: 10.1093/ajrccm/aamag031